Autoanticorps en neurologie: implications cliniques [Autoantibodies in neurological diseases: clinical implications]

Détails

ID Serval
serval:BIB_FA29E4C29502
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Autoanticorps en neurologie: implications cliniques [Autoantibodies in neurological diseases: clinical implications]
Périodique
Revue Médicale Suisse
Auteur(s)
Lalive P.H., Chofflon M., Du Pasquier R.A., Burkhard P.R.
ISSN
1660-9379
Statut éditorial
Publié
Date de publication
2009
Volume
5
Numéro
201
Pages
942-944, 946-948, 950
Langue
français
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Résumé
Autoantibodies are defined as antibodies directed against self antigens, i.e., against a normal antigenic endogenous tissue constituent. They can be the immediate cause of the neurological syndrome or be detected as an epiphenomenon of the pathogenic process. Autoantibodies are often considered useful biomarkers for the improvement of diagnostic accuracy, for the staging of disease progression or for the follow up of a biological response to a therapeutic intervention. The purpose of this article is to review the autoantibodies that are available to investigate immune-mediated neurological conditions. The detection of some of these autoantibodies may help the clinician to establish a definite diagnosis which may further facilitate the therapeutic decision.
Mots-clé
Autoantibodies/analysis, Autoimmune Diseases of the Nervous System/immunology, Biological Markers/analysis, Humans
Pubmed
Création de la notice
24/11/2009 1:29
Dernière modification de la notice
03/03/2018 22:55
Données d'usage